Friday, August 11, 2017 7:08:27 AM
As for PP or a j/v. They will need Money to continue. but this time they have results to back them up with. Any dip should be short lived imho. if they can find a big partner, I will be happy. They pay for us. If that happens or not remains to be seen.
The last 3 months of the year will be crucial. We will have a six month update on the first 3 and a 3 month update on the remaining 6 patients of the second group. We should also, if we are lucky, get information on other cancers, such as GBM and maybe prostate.
Lots of things happening. I suspect an announcement that they will enter Phase 2 studies could propel us much higher. Now just let's hope the results are as good going forward with no recurrence. Otherwise, well, down we go. But so far, most shareholders are very happty with results. Not so much with share price, so maybe something is holding it down. We will see what happens when results drop in. Media attention could do wonders if it were to occur.
There are those who understand this much better than I do, so better check with them as well. i suggest the Stockhouse board for more info.
Best regards
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM